CERO
USDCERo Therapeutics Holdings Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$0.335
고가
$0.095
저가
$0.095
거래량
8.44M
기업 기본 정보
시가총액
177.4K
산업
생명공학
국가
United States
거래 통계
평균 거래량
2.29M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
Maxim Group Downgrades CERo Therapeutics Hldgs to Hold
Maxim Group analyst Jason McCarthy downgrades CERo Therapeutics Hldgs from Buy to Hold.
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target
D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs with a Buy and maintains $30 price target.
CERo Therapeutics Announces Receipt of Nasdaq Panel Determination
Trading of the Company's shares of common stock on Nasdaq will be suspended at the open of trading on October 31 CERo plans to appeal the Panel determination, seek trading of its shares on the OTC Markets and continue
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target
D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs with a Buy and maintains $30 price target.
CERo Therapeutics Announces Third Dose for Patient in Phase 1 Clinical Trial of CER-1236 in AML
Company completes first tranche of a $7 million financing to increase cash runway and maintain Nasdaq compliance SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc.
CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company, announces that Chris Ehrlich,
